Stephen Schultz MD in Greenfield, Indiana

Home Indiana Greenfield

Stephen Schultz MD has Medical Oncology as his primary medical specialty. Their primary office is: 801 N State St in Greenfield, Indiana. There is an additional office location, for a total of two, for Stephen Schultz MD that can be viewed further down.

They're a part of the: Hancock Regional Hospital medical group which has around 45 members. You can call their office at 317-325-2273 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Minnesota Medical School and graduated in 1982 (around 42 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Stephen M Schultz MD Office Phone and Directions

Stephen Schultz MD
Hancock Regional Hospital
801 N State St
Greenfield, Indiana 46140
317-325-2273

Patient Ratings
Please rate your experience with Stephen Schultz MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 317-325-2273

Enter a starting address:

Healthcare Info for Stephen Schultz MD

Medical School: University Of Minnesota Medical School
Graduation Year: 1982
The Primary Medical Specialty for Stephen Schultz MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 42
PAC (PECOS ID)#: 9234189655
NPI #: 1033188719
NPI Created On: 03/16/2006
NPI Last Updated Listed as: 03/29/2021
Primary Taxonomy Code: 207RH0003X
License Number:
01034317A
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Celtic Insurance Company
CareSource
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Blood creatinine level
Complete blood cell count (red cells, white blood cell, platelets), automated test
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Therapeutic removal of whole blood to correct blood level imbalance
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
Injection, fluorouracil, 500 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788954819

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788954821

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788954823

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014661

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802374013

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ZEJULA

Open Associated Drug #1: 69656-103-90

Payments Total: $80

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832140493

Being Disputed:: No

Product Related: No

Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783685783

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01

Payments Total: $25

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783466993

Being Disputed:: No

Product Related: No

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835979953

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Perjeta

Open Associated Drug #1: 50242-145-01

Drug or Biological: Biological

Product Category #2: BioOncology

Name Of Drug #2:: Kadcyla

Associated Drug #2: 50242-087-01

Drug or Biological #3:: Biological

Product Category #3: BioOncology

Name of Drug: Phesgo

Name Of Drug #3: 50242-245-01

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813239441

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Additional Office Locations

1. Hancock Regional Hospital
4055 Roy Wilson Way
New Palestine, IN 46163
150 Hancock Regional Physician Group
Group Members: 45

Phone: 317-325-2273

Enter a starting address:

Providers in Hancock Regional Hospital

1.William Adams

1 Memorial Sq
Greenfield In 46140-1380
Hancock Regional Hospital
Podiatry

2.Sewit Amde

801 N State St
Greenfield In 46140-1270
Hancock Regional Hospital
Plastic And Reconstructive Surgery

3.Mirza Baig

801 N State St
Greenfield In 46140-1270
Hancock Regional Hospital
Nephrology

4.Markian Bochan

801 N State St
Greenfield In 46140-1270
Hancock Regional Hospital
Infectious Disease

5.Monet Bowling

801 N State St
Greenfield In 46140-1270
Hancock Regional Hospital
Surgical Oncology

6.Claudia Brinkruff

8505 N Clearview Dr
Mccordsville In 46055-6231
Hancock Regional Hospital
Registered Dietitian Or Nutrition Professional

View all 45 members of Hancock Regional Hospital medical group